An NFL Partnership for Sickle Cell? Genetix Is Betting on Cultural Reach for a...
Marketing for rare disease awareness comes with a basic challenge: how do you make a complex health issue feel relevant to people who may...
Regeneron Made Science Feel Like Meditation. That’s More Radical Than It Sounds.
Regeneron has done something unusual with scientific communication. Instead of making the science faster, louder, or more promotional, it slowed everything down. Its Science...
Same HCP List. Same Budget. 32% More Doctors. What Changed?
The same physician list, budget, creative, flight dates, and bid strategy should produce roughly the same reach, right? A recent specialty pharma test suggests...
A Sample Request Isn’t Just a Sample Request Anymore
For years, pharmaceutical sampling was largely viewed as a rep-driven transaction. A healthcare professional asked for a product sample, the request was processed, and...
Two Hospitals, Two Different Markets: The 340B Problem Pharma Can’t Ignore
Two hospitals may serve the same therapeutic market, treat similar patients, and sit only miles apart. Yet their pharmacy economics and access environments can...
Who Really Pays for Patient Assistance? Pharma’s Growing AFP Problem
Alternative funding programs in pharma were once viewed mainly as a payer issue, but they are becoming a much broader patient-access challenge. These programs...
What Happens When the Government Enters the Pharma Customer Journey?
For decades, pharmaceutical marketers have worked with a fairly familiar customer journey. A patient sees an ad, searches for a condition or branded drug,...
Can Every Patient Actually Use Your Pharma Website?
It’s easy to treat pharma website accessibility as little more than a technical checklist. Yet for patients, the questions are much more basic: Can...
Your Drug Didn’t Get Approved. Now the FDA Can Tell Everyone Why.
The communications playbook for a failed drug approval has changed. Complete Response Letters, or CRLs, once remained largely between the FDA and drug sponsors....
Stop Treating APPs Like Doctors: The Audience Pharma Keeps Underserving
Pharma marketing has a growing APP audience problem. Nurse practitioners (NPs), physician assistants/associates (PAs), and other advanced practice providers (APPs) now play major roles...
